ASN892713 Supplemental Material - Supplemental material for Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells

Supplemental material, ASN892713 Supplemental Material for Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells by Paula M. Wagner, Natalia M. Monjes and Mario E. Guido in ASN Neuro